KYTX β€” KYVERNA THERAPEUTICS INC

Ownership history in HEIGHTS CAPITAL MANAGEMENT, INC  Β·  1 quarter on record

This page tracks every 13F SEC filing in which HEIGHTS CAPITAL MANAGEMENT, INC reported a position in KYVERNA THERAPEUTICS INC (KYTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

πŸ” Peak position
0.92% (2025 Q4)
πŸ“Š Avg. % of fund
0.92%
πŸ“… First filed
2025 Q4
πŸ“… Last filed
2025 Q4
⏱ Quarters held
1
% of Fund (quarterly)    KYTX price (monthly, adj. close)
πŸ“‹ Quarterly Holdings History 1 quarter  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 INITIATED 271,822 β€” β€” 0.92% $2.6M $9.40

🏒 Other funds also holding KYTX

As of 2025 Q4 β€” sorted by position size

GordonMD Global Investments LP 29.6% Propel Bio Management, LLC 5.35% CAXTON CORP 3Y 7Y 4.12% AIGH Capital Management LLC 3Y 3.41% Bain Capital Life Sciences Investors, LLC 3Y 7Y 2.24% GILEAD SCIENCES, INC. 2.0% Monashee Investment Management LLC 3Y 7Y 1.03% Insight Holdings Group, LLC 3Y 7Y 0.7% MBB PUBLIC MARKETS I LLC 3Y 0.6% NANO CAP NEW MILLENNIUM GROWTH FUND L P 0.43%
← Back to HEIGHTS CAPITAL MANAGEMENT, INC Holdings